Developer docs
API playgroundTry for free, no card

Search company profiles

BioMedWire

Full company profile

uuid00spwvo

Namestring
BioMedWire
Legal namestring
BioMedWire
Websiteurl
biomedwire.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

BioMedWire (BMW) is a privately held B2B digital newswire and corporate communications service headquartered in Austin, Texas and incorporated in Delaware. It distributes corporate news, press releases, earnings statements, and branded editorial content on behalf of publicly traded and pre-IPO life sciences issuers—biotechnology, pharmaceutical, biomedical device, and nutraceutical companies—targeting retail and institutional investors, day traders, financial journalists, and fund managers. The company operates as one of more than 50 brands within the InvestorBrandNetwork (IBN) ecosystem and is positioned against incumbent wire services such as BusinessWire (a Berkshire Hathaway subsidiary) and PR Newswire (a Cision subsidiary), competing on sector specialization and the breadth of the bundled IBN stack.

The product portfolio is anchored by the IBNAi-powered digital newswire and content syndication engine and includes the tiered Brand Awareness Distribution (BAD) suite (Professional, Bulk, and Agency Bulk packages), Press Release Enhancement, Social Media Solutions, full-stack Corporate Communications covering investor relations, public relations, video production, and web services, plus the audio products AudioPressRelease (APR) and NetworkNewsAudio. Distribution scales through 5,000+ outlets spanning 55+ countries domestically and internationally, with the IBN network contributing a 2+ million social follower audience for amplification.

Revenue is generated through direct sales of tiered BAD packages priced on 5-day, 12-24 day, and 36-48+ day windows, plus multi-year subscription-style client-partner agreements sold on non-cancelable, non-refundable terms. Approximately 300+ companies have used BMW's tools cumulatively. The company also accepts cryptocurrency payments (Bitcoin, Ethereum, USDC), broadening its addressable buyer pool to digital-asset-native biotech issuers. No outside investors or funding events are disclosed, and the business operates as a privately held services firm within the broader IBN umbrella rather than as an independent venture-backed platform.

Short descriptiontext

BioMedWire is a privately held B2B digital newswire and corporate communications service that distributes press releases, earnings, and editorial content for publicly traded and pre-IPO life sciences issuers to investors, traders, journalists, and fund managers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotech press release distribution, life sciences newswire, corporate communications services, investor relations publishing, editorial content syndication
Industry1 code
1Healthcare & Life Sciences PR
CodeMPAAADADPrimaryYes
NAICS code1 code
  • Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers516210
Product category
Newswire and Corporate Communications Services
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Press Release Distribution Services
TypeSubscription Recurring
Description

BioMedWire receives cash compensation from companies (in the form of cash, check, credit card, and wire payments) for disseminating advertising, marketing news distribution, and public relations solutions on their behalf. Companies pay fees for press release enhancement, syndication, and distribution services.

biomedwire.com
2Brand Awareness Solutions
TypeSubscription Recurring
Description

Fees for brand awareness campaigns, corporate communications, and marketing services. The GTSA indicates payment obligations are non-cancelable with fees paid being non-refundable, suggesting recurring subscription-type revenue from ongoing client-partner relationships.

biomedwire.com
3Client-Partner Services
TypeSubscription Recurring
Description

Comprehensive suite of communications tools including Brand Awareness, Corporate Communications, Syndicated Communications, Press Release Enhancement, and Social Media Solutions delivered under subscription agreements with tiered campaign options (BAD Professional, BAD Bulk, BAD Agency Bulk).

biomedwire.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details3 tiers
1BAD Professional Campaign - 5 days of continuous North American coverage with multi-ticker tagged editorial articles and amplified traffic generation
ModelSubscriptionBilling cadenceMulti-year contract
Notes

5 Days of BAD North American Complete Coverage; 2 Multi-Ticker Tagged Syndication Editorial Articles; 2 Additional Days of Coverage; Amplified Traffic Generation across North America

biomedwire.com
2BAD Bulk Campaign - 12-24 days of branded coverage with multiple syndicated editorial articles
ModelSubscriptionBilling cadenceMulti-year contract
Notes

12-24 Days of BAD BULK Complete Professional Coverage with BULK discount rates available

biomedwire.com
3BAD Agency Bulk Campaign - 36-48+ days of coverage for multiple public companies
ModelSubscriptionBilling cadenceMulti-year contract
Notes

36-48+ Days of BAD Agency BULK Complete Professional Coverage with Agency BULK discount rates

biomedwire.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BioMedWire is a newswire and publishing service within the InvestorBrandNetwork (IBN) ecosystem that distributes corporate news, press releases, and editorial content for medical, biotechnology, and life sciences companies. It packages press release syndication, editorial coverage, and social media amplification for paying issuer clients, syndicating content through a network of 5,000+ media outlets, financial portals, and downstream channels.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reaches millions of investors through 5,000+ distribution outlets
+1 more record
Product overview1 text field

BioMedWire (BMW) is a technology-driven digital news and publishing platform for the medical and biotechnology sector, operating as part of the InvestorBrandNetwork (IBN). The core offering is the BioMedWire newswire service, which provides syndicated communications across 5,000+ distribution outlets. The platform operates on a modular architecture comprising: core BioMedWire news aggregation and syndication; Brand Awareness Distribution (BAD) for ticker-tagged editorial syndication and digital traffic generation; Press Release Enhancement for editorial quality; Social Media Solutions for multi-platform amplification; Corporate Communications including investor relations and public relations services; and Video Production capabilities. Add-on modules include AudioPressRelease (APR) and NetworkNewsAudio podcast distribution, website development, and the Client-Partner program providing extended coverage features.

Product and service4 records
1BioMedWire Press Release Distribution
CategoryNewswire and corporate communications services
Description

Wire-format press release distribution service for publicly traded and emerging biotech, pharmaceutical, and life sciences companies, syndicating corporate news across a network of 5,000+ media outlets, financial portals, and downstream channels. Targeted at IR and corporate communications buyers at life sciences issuers.

2BioMedWire Editorial Coverage
CategoryEditorial and content publishing
Description

Editorial-authored and editorial-reviewed content pieces published and syndicated for life sciences clients to support investor awareness campaigns, conference coverage, and corporate milestone announcements. Targeted at biotech and life sciences issuers needing third-party credibility.

3BioMedWire Social Media and RSS Amplification
CategorySocial media and RSS syndication
Description

Social media channel and RSS feed distribution of client corporate news to expand reach beyond traditional wire endpoints, integrated with BioMedWire's syndication workflow. Targeted at IR and corporate communications teams seeking broader retail-investor and social reach.

4InvestorBrandNetwork (IBN) Integrated Communications Bundle
CategoryIntegrated investor communications services
Description

Combined communications and distribution offering spanning BioMedWire's life-sciences-specialized services together with other IBN vertical wires, providing multi-sector editorial, syndication, and investor relations support to publicly traded issuers. Targeted at issuers needing multi-vertical communications coverage under one vendor relationship.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major financial portal for news distribution, providing exposure to retail investors and financial professionals through news syndication.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Tier-one financial news destination for ticker-tagged editorial syndication and press release distribution.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

International financial news agency for global distribution of branded content.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Broadcast financial media partner for digital news portal distribution and financial content syndication.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Financial news and media outlet for digital traffic generation and investor visibility.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Brokerage platform for financial news distribution to active investors and traders.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Brokerage terminal partner for news and press release syndication to investor demographics.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major financial newspaper and news portal for premium news syndication and investor reach.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Financial publication partner for news distribution and editorial syndication.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Press release wire service partner for additional coverage via IW North American Plus distribution.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Financial data and charting platform for ticker-tagged editorial syndication targeting investors.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Financial terminal and news service for comprehensive news distribution to institutional and retail investors.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Parent/organizational network providing 50+ trusted brands and 2+ million social media followers for Core Client Partner Coverage. BioMedWire is powered by IBN.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Conference and event partner for biotech/life sciences industry visibility.

15DGE Dynamic Global Events
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Healthcare conference partner for event marketing and industry visibility.

biomedwire.com
16DTC Healthcare Conference
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Healthcare-focused conference partner for event marketing and industry exposure.

biomedwire.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Research and market intelligence partner for life sciences sector coverage.

18Nexus Conferences
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Conference partner for industry event presence and networking opportunities.

biomedwire.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Conference and events partner for life sciences and healthcare industry visibility.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Parent company of PR Newswire and Marketwired; broader incumbent in PR software, media monitoring, and communications workflow. Operates as an established incumbent in BioMedWire's category with a much wider product portfolio.

TypeEmerging player
Description

Smaller, newer digital press release distribution service focused on affordable wire distribution for SMBs. Partial overlap with BioMedWire's pay-as-you-go positioning for smaller issuers.

TypeDirect peer
Description

Press release distribution service focused on small and mid-cap public companies. Closely comparable business model to BioMedWire, particularly in target client segment.

TypeDirect peer
Description

Press release distribution service with broad wire and SEO syndication across news networks and financial sites. Directly comparable service offering for small/mid-cap public company communications.

TypeEmerging player
Description

Affordable digital press release distribution service targeting small businesses and startups. Comparable low-cost distribution offering versus BioMedWire's no-contract positioning.

TypeDirect peer
Description

Press release distribution service owned by Notified (formerly part of Intrado). BioMedWire explicitly lists GlobeNewswire as a direct competitor in its own comparison marketing material.

TypeDirect peer
Description

Major press release distribution service owned by Cision, serving public companies and PR agencies with wire distribution and media monitoring. Direct competitor in the same wire distribution category.

TypeDirect peer
Description

Press release distribution service offering wire, SEO, and social media distribution to a similar SMB and small-cap public company client base. Comparable offering scope and pricing tier.

TypeDirect peer
Description

Largest direct competitor in press release wire distribution, owned by Berkshire Hathaway. Serves similar B2B communications clients with comparable wire, social, and financial portal syndication; BioMedWire explicitly compares against it as a benchmark.

TypeDirect peer
Description

Sibling brand within the same InvestorBrandNetwork (IBN) ecosystem. Operates the same wire distribution / syndication model with the same parent infrastructure but targets the broader investor market rather than life sciences specifically.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioMedWire

Newswire and Corporate Communications Servicesbiomedwire.com

BioMedWire is a privately held B2B digital newswire and corporate communications service that distributes press releases, earnings, and editorial content for publicly traded and pre-IPO life sciences issuers to investors, traders, journalists, and fund managers.

What BioMedWire does

BioMedWire (BMW) is a privately held B2B digital newswire and corporate communications service headquartered in Austin, Texas and incorporated in Delaware. It distributes corporate news, press releases, earnings statements, and branded editorial content on behalf of publicly traded and pre-IPO life sciences issuers—biotechnology, pharmaceutical, biomedical device, and nutraceutical companies—targeting retail and institutional investors, day traders, financial journalists, and fund managers. The company operates as one of more than 50 brands within the InvestorBrandNetwork (IBN) ecosystem and is positioned against incumbent wire services such as BusinessWire (a Berkshire Hathaway subsidiary) and PR Newswire (a Cision subsidiary), competing on sector specialization and the breadth of the bundled IBN stack.

The product portfolio is anchored by the IBNAi-powered digital newswire and content syndication engine and includes the tiered Brand Awareness Distribution (BAD) suite (Professional, Bulk, and Agency Bulk packages), Press Release Enhancement, Social Media Solutions, full-stack Corporate Communications covering investor relations, public relations, video production, and web services, plus the audio products AudioPressRelease (APR) and NetworkNewsAudio. Distribution scales through 5,000+ outlets spanning 55+ countries domestically and internationally, with the IBN network contributing a 2+ million social follower audience for amplification.

Revenue is generated through direct sales of tiered BAD packages priced on 5-day, 12-24 day, and 36-48+ day windows, plus multi-year subscription-style client-partner agreements sold on non-cancelable, non-refundable terms. Approximately 300+ companies have used BMW's tools cumulatively. The company also accepts cryptocurrency payments (Bitcoin, Ethereum, USDC), broadening its addressable buyer pool to digital-asset-native biotech issuers. No outside investors or funding events are disclosed, and the business operates as a privately held services firm within the broader IBN umbrella rather than as an independent venture-backed platform.

BioMedWire firmographics

Firmographics
Name
BioMedWire
Legal name
BioMedWire
Website
https://biomedwire.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
BioMedWire is a privately held B2B digital newswire and corporate communications service that distributes press releases, earnings, and editorial content for publicly traded and pre-IPO life sciences issuers to investors, traders, journalists, and fund managers.
Ownership category
akta.pro rank

BioMedWire industry classification

Industry
Product category
Newswire and Corporate Communications Services
NAICS
Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers (516210)
akta.pro primary industry
Healthcare & Life Sciences PR (MPAAADAD)

Keywords

  • Biotech press release distribution
  • Life sciences newswire
  • Corporate communications services
  • Investor relations publishing
  • Editorial content syndication

Where BioMedWire is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BioMedWire business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Press Release Distribution Services: BioMedWire receives cash compensation from companies (in the form of cash, check, credit card, and wire payments) for disseminating advertising, marketing news distribution, and public relations solutions on their behalf. Companies pay fees for press release enhancement, syndication, and distribution services.
  2. Brand Awareness Solutions: Fees for brand awareness campaigns, corporate communications, and marketing services. The GTSA indicates payment obligations are non-cancelable with fees paid being non-refundable, suggesting recurring subscription-type revenue from ongoing client-partner relationships.
  3. Client-Partner Services: Comprehensive suite of communications tools including Brand Awareness, Corporate Communications, Syndicated Communications, Press Release Enhancement, and Social Media Solutions delivered under subscription agreements with tiered campaign options (BAD Professional, BAD Bulk, BAD Agency Bulk).

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractBAD Professional Campaign - 5 days of continuous North American coverage with multi-ticker tagged editorial articles and amplified traffic generation
SubscriptionMulti-year contractBAD Bulk Campaign - 12-24 days of branded coverage with multiple syndicated editorial articles
SubscriptionMulti-year contractBAD Agency Bulk Campaign - 36-48+ days of coverage for multiple public companies

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

BioMedWire product offering

Product offering

Core offering

BioMedWire is a newswire and publishing service within the InvestorBrandNetwork (IBN) ecosystem that distributes corporate news, press releases, and editorial content for medical, biotechnology, and life sciences companies. It packages press release syndication, editorial coverage, and social media amplification for paying issuer clients, syndicating content through a network of 5,000+ media outlets, financial portals, and downstream channels.

Product overview

BioMedWire (BMW) is a technology-driven digital news and publishing platform for the medical and biotechnology sector, operating as part of the InvestorBrandNetwork (IBN). The core offering is the BioMedWire newswire service, which provides syndicated communications across 5,000+ distribution outlets. The platform operates on a modular architecture comprising: core BioMedWire news aggregation and syndication; Brand Awareness Distribution (BAD) for ticker-tagged editorial syndication and digital traffic generation; Press Release Enhancement for editorial quality; Social Media Solutions for multi-platform amplification; Corporate Communications including investor relations and public relations services; and Video Production capabilities. Add-on modules include AudioPressRelease (APR) and NetworkNewsAudio podcast distribution, website development, and the Client-Partner program providing extended coverage features.

Differentiator

Problem solved

Functional benefit

Products and services

  • BioMedWire Press Release Distribution Wire-format press release distribution service for publicly traded and emerging biotech, pharmaceutical, and life sciences companies, syndicating corporate news across a network of 5,000+ media outlets, financial portals, and downstream channels. Targeted at IR and corporate communications buyers at life sciences issuers.
  • BioMedWire Editorial Coverage Editorial-authored and editorial-reviewed content pieces published and syndicated for life sciences clients to support investor awareness campaigns, conference coverage, and corporate milestone announcements. Targeted at biotech and life sciences issuers needing third-party credibility.
  • BioMedWire Social Media and RSS Amplification Social media channel and RSS feed distribution of client corporate news to expand reach beyond traditional wire endpoints, integrated with BioMedWire's syndication workflow. Targeted at IR and corporate communications teams seeking broader retail-investor and social reach.
  • InvestorBrandNetwork (IBN) Integrated Communications Bundle Combined communications and distribution offering spanning BioMedWire's life-sciences-specialized services together with other IBN vertical wires, providing multi-sector editorial, syndication, and investor relations support to publicly traded issuers. Targeted at issuers needing multi-vertical communications coverage under one vendor relationship.

Quantifiable outcome

  • Reaches millions of investors through 5,000+ distribution outlets
  • +1 more outcomes

Companies that use BioMedWire

Customer profile

Segments4 records

Ideal customer profiles1 record

BioMedWire technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability3 records

Feature5 records

BioMedWire partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered core and minor.

  • Yahoo FinancecoreChannel Partner/ Reseller/ DistributorMajor financial portal for news distribution, providing exposure to retail investors and financial professionals through news syndication.
  • MarketWatchcoreChannel Partner/ Reseller/ DistributorTier-one financial news destination for ticker-tagged editorial syndication and press release distribution.
  • ReuterscoreChannel Partner/ Reseller/ DistributorInternational financial news agency for global distribution of branded content.
  • CNBCcoreChannel Partner/ Reseller/ DistributorBroadcast financial media partner for digital news portal distribution and financial content syndication.
  • BenzingacoreChannel Partner/ Reseller/ DistributorFinancial news and media outlet for digital traffic generation and investor visibility.
  • E*TRADEcoreChannel Partner/ Reseller/ DistributorBrokerage platform for financial news distribution to active investors and traders.
  • TD AmeritradecoreChannel Partner/ Reseller/ DistributorBrokerage terminal partner for news and press release syndication to investor demographics.
  • The Wall Street Journal (WSJ)coreChannel Partner/ Reseller/ DistributorMajor financial newspaper and news portal for premium news syndication and investor reach.
  • Barron'scoreChannel Partner/ Reseller/ DistributorFinancial publication partner for news distribution and editorial syndication.
  • GlobeNewswirecoreChannel Partner/ Reseller/ DistributorPress release wire service partner for additional coverage via IW North American Plus distribution.
  • BarchartcoreChannel Partner/ Reseller/ DistributorFinancial data and charting platform for ticker-tagged editorial syndication targeting investors.
  • BloombergcoreChannel Partner/ Reseller/ DistributorFinancial terminal and news service for comprehensive news distribution to institutional and retail investors.
  • InvestorBrandNetwork (IBN)coreChannel Partner/ Reseller/ DistributorParent/organizational network providing 50+ trusted brands and 2+ million social media followers for Core Client Partner Coverage. BioMedWire is powered by IBN.
  • BIO InformaminorChannel Partner/ Reseller/ DistributorConference and event partner for biotech/life sciences industry visibility.
  • DGE Dynamic Global EventsminorChannel Partner/ Reseller/ DistributorHealthcare conference partner for event marketing and industry visibility.
  • DTC Healthcare ConferenceminorChannel Partner/ Reseller/ DistributorHealthcare-focused conference partner for event marketing and industry exposure.
  • Kiasco ResearchminorChannel Partner/ Reseller/ DistributorResearch and market intelligence partner for life sciences sector coverage.
  • Nexus ConferencesminorChannel Partner/ Reseller/ DistributorConference partner for industry event presence and networking opportunities.
  • OctaneminorChannel Partner/ Reseller/ DistributorConference and events partner for life sciences and healthcare industry visibility.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

BioMedWire competitors and assessment

Company assessment

Broad incumbents

  • Cision: Parent company of PR Newswire and Marketwired; broader incumbent in PR software, media monitoring, and communications workflow. Operates as an established incumbent in BioMedWire's category with a much wider product portfolio.

Emerging players

  • iCrowdNewswire: Smaller, newer digital press release distribution service focused on affordable wire distribution for SMBs. Partial overlap with BioMedWire's pay-as-you-go positioning for smaller issuers.
  • IssueWire: Affordable digital press release distribution service targeting small businesses and startups. Comparable low-cost distribution offering versus BioMedWire's no-contract positioning.

Direct peers

  • ACCESSWIRE: Press release distribution service focused on small and mid-cap public companies. Closely comparable business model to BioMedWire, particularly in target client segment.
  • EIN Presswire: Press release distribution service with broad wire and SEO syndication across news networks and financial sites. Directly comparable service offering for small/mid-cap public company communications.
  • GlobeNewswire: Press release distribution service owned by Notified (formerly part of Intrado). BioMedWire explicitly lists GlobeNewswire as a direct competitor in its own comparison marketing material.
  • PR Newswire (Cision): Major press release distribution service owned by Cision, serving public companies and PR agencies with wire distribution and media monitoring. Direct competitor in the same wire distribution category.
  • 24-7 Press Release Newswire: Press release distribution service offering wire, SEO, and social media distribution to a similar SMB and small-cap public company client base. Comparable offering scope and pricing tier.
  • Business Wire: Largest direct competitor in press release wire distribution, owned by Berkshire Hathaway. Serves similar B2B communications clients with comparable wire, social, and financial portal syndication; BioMedWire explicitly compares against it as a benchmark.
  • InvestorWire: Sibling brand within the same InvestorBrandNetwork (IBN) ecosystem. Operates the same wire distribution / syndication model with the same parent infrastructure but targets the broader investor market rather than life sciences specifically.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

BioMedWire social profiles

Digital presence

BioMedWire financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioMedWire leadership team

Management profile

Number of profiles

Profiles1 record

BioMedWire funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioMedWire M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioMedWire

What does BioMedWire do?

BioMedWire is a newswire and publishing service within the InvestorBrandNetwork (IBN) ecosystem that distributes corporate news, press releases, and editorial content for medical, biotechnology, and life sciences companies. It packages press release syndication, editorial coverage, and social media amplification for paying issuer clients, syndicating content through a network of 5,000+ media outlets, financial portals, and downstream channels.

Is BioMedWire a public or private company?

BioMedWire is a private company. It is classified as corporate owned and is currently operating.

When was BioMedWire founded?

BioMedWire was founded in -1. It employs 1 to 10 people.

Where is BioMedWire based?

BioMedWire is headquartered in Austin, United States, in the North America region.

How does BioMedWire make money?

Three revenue lines are on record. Press Release Distribution Services are the primary driver. The others are brand Awareness Solutions and client-Partner Services.

Who are BioMedWire's main competitors?

Cision is listed as a broad incumbent. Emerging players are iCrowdNewswire and IssueWire. Direct peers are ACCESSWIRE, EIN Presswire, GlobeNewswire, PR Newswire (Cision), 24-7 Press Release Newswire, Business Wire and InvestorWire.

Does BioMedWire have an API?

No public API is recorded for BioMedWire.

What industry is BioMedWire in?

BioMedWire's product category is Newswire and Corporate Communications Services. Its primary akta.pro industry code is MPAAADAD, Healthcare & Life Sciences PR. Its NAICS code is 516210.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanOnco-Innovations in BioMedWire editorial on ONC010Onco-Innovations Limited was featured in a BioMedWire editorial highlighting its clinical-stage oncology work, specifically its ONC010 nanoparticle-encapsulated PNKP inhibitor designed to target DNA repair enzymes in cancer cells. The DDR inhibitor market generated over $7 billion in worldwide sales in 2025, with the broader oncology, diagnostics, and precision medicine markets expected to reach approximately $750 billion by 2030, positioning this inhibitor class as a significant emerging opportunity.Stock TitanOnco-Innovations in BioMedWire editorial on ONC010Onco-Innovations Limited, a Canadian clinical-stage oncology company, announced its placement in a BioMedWire editorial highlighting its nanoparticle-encapsulated PNKP inhibitor drug candidate ONC010(TM) targeting DNA repair in cancer cells. The editorial discusses the broader DNA Damage Response inhibitor (DDRi) market, which generated an estimated $7 billion-plus in global sales in 2025, with the broader oncology, diagnostics, and precision medicine markets projected to reach approximately $750 billion by 2030. Onco-Innovations holds an exclusive worldwide license to patented technology targeting solid tumors.Stock TitanOncotelic in BioMedWire piece on CNS drug deliveryOncotelic Therapeutics Inc. (OTCQB: OTLC) announced its placement in a BioMedWire editorial titled "CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research," highlighting the company's proprietary intranasal nose-to-brain (N2B) drug delivery system designed to circumvent the blood-brain barrier for targeted CNS therapeutics.GlobeNewswireIBN and BioMedWire Announce Fifth Year as Official Media Partners for Dynamic Global Events’ (DGE) 2025 Life Sciences ConferencesIBN and BioMedWire announced their fifth consecutive year as official media partners for Dynamic Global Events' 2025 life sciences conferences. The partnership includes virtual coverage and social media promotion across IBN's network of over 5,000 partners and 2 million followers. Additional events will be announced in coming weeks.GlobeNewswireIBN and BioMedWire Named Official Media Partners for BioPharma Nexus Events in 2024IBN and BioMedWire will serve as official media partners for BioPharma Nexus events in 2024, covering USA and Europe. The partnership includes syndicated articles to 5,000+ outlets and live social media updates. BioPharma Nexus organizes conferences on clinical trials, drug discovery, and supply chains.GlobeNewswireIBN and BioMedWire Named Official Media Partners for BioPharma Nexus Events in October 2023IBN and BioMedWire will serve as official media partners for BioPharma Nexus events in October 2023, including four conferences in Philadelphia. The partnership includes syndicated articles to 5,000+ outlets and social media updates. The events cover clinical trials, medical affairs, drug discovery, and supply chain logistics.GlobeNewswireIBN and BioMedWire Announce 3rd Year of Collaboration with Dynamic Global Events (DGE) to Serve as Official Media Partners for Upcoming 2023 EventsIBN and BioMedWire will serve as official media partners for Dynamic Global Events' 2023 life sciences conferences. The partnership includes dedicated virtual coverage and syndication to 5,000+ partners, with events listed from February to November 2023.GlobeNewswireIBN and BioMedWire Announce 2nd Year of Collaboration with Dynamic Global Events as Official Media Partners for the 2022 Event Line-UpIBN and BioMedWire announced they will serve as official media partners for Dynamic Global Events' 2022 life science events. The collaboration aims to increase visibility for DGE's events, which include Advancing Women's Leadership and Virtual Clinical Trials. IBN's syndication network reaches 5,000+ news outlets.GlobeNewswireInvestorBrandNetwork (IBN) and BioMedWire (BMW) Announce Collaboration with Q1 Productions to Serve as Official Media Sponsors for Upcoming Event ScheduleInvestorBrandNetwork and BioMedWire announced they will sponsor Q1 Productions' 2021 event lineup, including conferences on medical devices and regulatory affairs. The partnership includes professionally written articles syndicated to over 5,000 news outlets and social media coverage. Q1 Productions' CEO Paul Northover said the collaboration will help reach larger audiences.GlobeNewswireInvestorBrandNetwork (IBN) and BioMedWire (BMW) Announce Collaboration with Dynamic Global Events (DGE) to Serve as Official Media Partners for Upcoming 2021 EventsInvestorBrandNetwork and BioMedWire announced they will partner with Dynamic Global Events as official media partners for 2021 life sciences events. The collaboration includes virtual coverage, syndication to 5,000+ outlets, and social media promotion across IBN's 2 million+ followers. Additional events will be announced in coming weeks.